| scholarly article | Q13442814 |
| P50 | author | John V Frangioni | Q87480257 |
| P2093 | author name string | Roger J Hajjar | |
| Alec M De Grand | |||
| Yoshiaki Kawase | |||
| Judith K Gwathmey | |||
| Federica Del Monte | |||
| Tsuyoshi Tsuji | |||
| Kozo Hoshino | |||
| Jennifer McGregor | |||
| Motoya Hayase | |||
| Ryuichi Yoneyama | |||
| Briain D Macneill | |||
| P2860 | cites work | A simplified system for generating recombinant adenoviruses | Q24682328 |
| Improvement in survival and cardiac metabolism after gene transfer of sarcoplasmic reticulum Ca(2+)-ATPase in a rat model of heart failure | Q28354203 | ||
| Prospects for gene therapy for heart failure | Q33881236 | ||
| Adenoviral gene transfer of SERCA2a improves left-ventricular function in aortic-banded rats in transition to heart failure | Q34978011 | ||
| Clinical use of inotropic therapy for heart failure: looking backward or forward? Part I: inotropic infusions during hospitalization | Q35183082 | ||
| Clinical use of inotropic therapy for heart failure: looking backward or forward? Part II: chronic inotropic therapy | Q35186772 | ||
| Widespread long-term gene transfer to mouse skeletal muscles and heart | Q35605664 | ||
| Modulation of ventricular function through gene transfer in vivo | Q36067860 | ||
| An operational near-infrared fluorescence imaging system prototype for large animal surgery | Q40546399 | ||
| Catheter-based intracoronary myocardial adenoviral gene delivery: importance of intraluminal seal and infusion flow rate. | Q40569551 | ||
| Systemic delivery of recombinant proteins by genetically modified myoblasts | Q41653223 | ||
| How to optimize in vivo gene transfer to cardiac myocytes: mechanical or pharmacological procedures? | Q43727635 | ||
| In vivo myocardial gene transfer: optimization and evaluation of intracoronary gene delivery in vivo | Q43856052 | ||
| Safety and efficacy of in vivo gene transfer into the porcine heart with replication-deficient, recombinant adenovirus vectors | Q45114912 | ||
| Gene delivery to the myocardium by intrapericardial injection. | Q45862161 | ||
| Myocardial gene transfer by selective pressure-regulated retroinfusion of coronary veins | Q45865601 | ||
| Percutaneous transluminal in vivo gene transfer by recombinant adenovirus in normal porcine coronary arteries, atherosclerotic arteries, and two models of coronary restenosis | Q45871121 | ||
| Focal modification of electrical conduction in the heart by viral gene transfer | Q45872810 | ||
| Efficient gene transfer into myocardium by direct injection of adenovirus vectors | Q64377591 | ||
| Direct in vivo gene transfer to canine myocardium using a replication-deficient adenovirus vector | Q64382776 | ||
| Ligaments and adipose tissue in the epidural space | Q71889041 | ||
| The anatomy of the coronary sinus and its tributaries | Q73920607 | ||
| P433 | issue | 6 | |
| P921 | main subject | catheterization | Q2312472 |
| P304 | page(s) | H2995-3000 | |
| P577 | publication date | 2005-06-01 | |
| P1433 | published in | American Journal of Physiology Heart and Circulatory Physiology | Q3193662 |
| P1476 | title | Catheter-based antegrade intracoronary viral gene delivery with coronary venous blockade | |
| P478 | volume | 288 |
| Q37982681 | Adjuvant early and late cardioprotective therapy: access to the heart. |
| Q37766138 | Advances in gene-based therapy for heart failure |
| Q45862445 | Cardiac Gene Delivery in Large Animal Models: Antegrade Techniques |
| Q34409721 | Cardiac Gene Therapy |
| Q38820937 | Cardiac gene therapy: are we there yet? |
| Q33832137 | Cardiac gene therapy: optimization of gene delivery techniques in vivo |
| Q36931967 | Current strategies for myocardial gene delivery |
| Q37766126 | Delivery of gene and cellular therapies for heart disease |
| Q37299072 | Designing heart performance by gene transfer. |
| Q45861410 | Gene Therapy in Heart Failure |
| Q36800517 | Gene therapy for cardiac arrhythmias: a dream soon to come true? |
| Q38132253 | Gene therapy for heart disease: molecular targets, vectors and modes of delivery to myocardium |
| Q83556143 | Gene therapy for heart failure |
| Q38073152 | Gene therapy for heart failure: where do we stand? |
| Q36944623 | Gene therapy in heart failure |
| Q36786243 | Gene therapy in the treatment of heart failure |
| Q40119187 | Gene-therapy delivery strategies in cardiology |
| Q33605156 | Heart failure management: the present and the future |
| Q57823807 | Human Cardiac Gene Therapy |
| Q88436950 | In Situ Heart Isolation Featuring Closed Loop Recirculation: The Gold Standard for Optimum Cardiac Gene Transfer? |
| Q36793908 | Intraoperative detection of cell injury and cell death with an 800 nm near-infrared fluorescent annexin V derivative. |
| Q36179776 | MRI roadmap-guided transendocardial delivery of exon-skipping recombinant adeno-associated virus restores dystrophin expression in a canine model of Duchenne muscular dystrophy. |
| Q38081027 | Mechanistic, technical, and clinical perspectives in therapeutic stimulation of coronary collateral development by angiogenic growth factors |
| Q35360600 | Methods to improve cardiac gene therapy expression |
| Q36582843 | Myocardial Delivery of Lipidoid Nanoparticle Carrying modRNA Induces Rapid and Transient Expression |
| Q30440788 | Myocardial gene transfer: routes and devices for regulation of transgene expression by modulation of cellular permeability |
| Q38113171 | Percutaneous approaches for efficient cardiac gene delivery. |
| Q37993680 | Percutaneous methods of vector delivery in preclinical models |
| Q35621815 | Percutaneous transendocardial delivery of self-complementary adeno-associated virus 6 achieves global cardiac gene transfer in canines. |
| Q36497159 | Potential of gene therapy as a treatment for heart failure |
| Q36757097 | Real-time intraoperative assessment of the extrahepatic bile ducts in rats and pigs using invisible near-infrared fluorescent light. |
| Q45879221 | Recirculating cardiac delivery of AAV2/1SERCA2a improves myocardial function in an experimental model of heart failure in large animals |
| Q37676218 | Sarcoplasmic reticulum Ca(2+) ATPase as a therapeutic target for heart failure |
| Q34082093 | Surgical methods for cardiac gene transfer |
| Q37878086 | Targeted gene therapy for the treatment of heart failure |
| Q35990749 | Targeted high-efficiency, homogeneous myocardial gene transfer |
| Q37550406 | Targeting sarcoplasmic reticulum calcium ATPase by gene therapy |
| Q36406450 | The future of regenerative therapy in patients with chronic heart failure |
| Q33705144 | The road ahead: working towards effective clinical translation of myocardial gene therapies |
| Q38128924 | Therapeutic potential of genes in cardiac repair |
| Q45858433 | Three catheter-based strategies for cardiac delivery of therapeutic gelatin microspheres |
| Q40199219 | Treatment of heart failure by calcium cycling gene therapy |
Search more.